Is Meta Still a “Buy” After Making History?
Going into February 2022, shares of Meta Platforms (Nasdaq: META) had been nearly cut in half over the prior six months. The steep…
Category: news
KFF Health News: Halfway Through ‘Unwinding,’ Medicaid Enrollment Is Down About 10 Million
Halfway through what will be the biggest purge of Medicaid beneficiaries in a one-year span, enrollment in the government-run health insurance program is…
How Risky Is Royalty Pharma’s Dividend?
You’re no doubt familiar with the concept of royalties – recurring payments that people receive for the continued use of their work. I…
Bonds Are the Place to Be Right Now
Last week, Sen. Elizabeth Warren asked Fed Chair Jerome Powell to reduce the “astronomical rates.” I’m not sure which planet she’s on, but…
Seniors Beware: Guaranteed Medicare Benefits at Risk if Trump Returns to Office
The following statement was issued by Richard Fiesta, Executive Director of the Alliance for Retired Americans, in response to a Rolling Stone magazine…
Does Geographic Arbitrage Make the American Dream Irrelevant?
“The American dream is a sham. Because I had the house, the cars, the kids. I did all of that, but even achieving…
Patience Pays Off in AI Investing
Editor’s Note: Today’s article comes from Senior Markets Expert Matt Benjamin. He details some of the exciting calls Chief Investment Strategist Alexander Green…
Is This the Only Cheap Tech Stock?
The best stocks to own for the long term aren’t average companies that were bought at really low valuations. No, the biggest stock…
KFF Health News: The FTC Is Attacking Drugmakers’ ‘Patent Thickets’
The Federal Trade Commission has challenged the validity of over 100 drug product patents, focusing on devices used to deliver medicines, like inhalers…